Laura Bracaglia

Title: Laura Bracaglia: Innovator in Targeting Platforms

Introduction

Laura Bracaglia is a prominent inventor based in New Haven, CT (US). She has made significant contributions to the field of biotechnology, particularly in the development of enhanced targeting platforms. Her innovative work focuses on creating technologies that improve the delivery of therapeutic agents to specific cells, tissues, and organs.

Latest Patents

Laura Bracaglia holds 1 patent for her invention titled "Enhanced Targeting Platform." This platform technology provides particle and nucleic acid conjugates, along with compositions that enhance targeting to cells, tissues, and organs. The technology involves synthetic binding proteins, such as polypeptide monobodies, which are covalently conjugated to the surface of particles or nucleic acids. This allows for the linking of targeting agents to the surfaces of these deliverables. Additionally, the particles can include therapeutic, diagnostic, or prophylactic agents, making them versatile for various applications, including ex vivo perfusion of mammalian organs and in vivo disease treatment.

Career Highlights

Throughout her career, Laura has worked with prestigious institutions, including Yale University and New York University. Her research has significantly advanced the understanding and application of targeted delivery systems in medicine.

Collaborations

Laura has collaborated with notable professionals in her field, including W Mark Saltzman and Gregory T Tietjen. These collaborations have further enriched her research and contributed to the development of her innovative technologies.

Conclusion

Laura Bracaglia is a trailblazer in the field of biotechnology, with her enhanced targeting platform representing a significant advancement in targeted delivery systems. Her work continues to influence the landscape of medical technology and therapeutic applications.